Emerging mitochondrial signaling mechanisms in physiology, aging processes, and as drug targets

Experimental Gerontology

Volumn 46, Issue 2-3, 2011, Pages 174-177

  Lakshminarasimhan, Mahadevan ^a   Steegborn, Clemens ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Aging; Calorie restriction; Cyclic nucleotide; Drug development; Mitochondria; P66Shc; Phosphodiesterase; Reactive oxygen species; Sirtuin

Indexed keywords

CYCLIC AMP; PROTEIN INHIBITOR; PROTEIN P66; REACTIVE OXYGEN METABOLITE; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; SIRTUIN INHIBITOR; UNCLASSIFIED DRUG;

ACETYLATION; AGING; ARTICLE; CELL FUNCTION; DEACETYLATION; DRUG TARGETING; ENERGY METABOLISM; HUMAN; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; STRESS;

AGING; ANIMALS; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 78751704777     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.08.024     Document Type: Article

References (30)

1. Acin-Perez R., Salazar E., Kamenetsky M., Buck J., Levin L.R., Manfredi G. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab. 2009, 9:265-276.
2. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
3. Conti M., Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 2007, 76:481-511.
4. Gertz M., Fischer F., Leipelt M., Wolters D., Steegborn C. Identification of Peroxiredoxin 1 as a novel interaction partner for the lifespan regulator protein p66Shc. Aging 2009, 1:254-265.
5. Gertz M., Fischer F., Wolters D., Steegborn C. Activation of the lifespan regulator p66Shc through reversible disulfide bond formation. Proc. Natl Acad. Sci. USA 2008, 105:5705-5709.
6. Gertz M., Steegborn C. Function and regulation of the mitochondrial Sirtuin isoform Sirt5 in Mammalia. Biochim. Biophys. Acta 2010, 1804:1658-1665.
7. Gertz M., Steegborn C. The lifespan-regulator p66Shc in mitochondria - redox enzyme or redox sensor?. Antioxid. Redox Signal. 2010, doi:10.1089/ars.2010.3147.
8. Guarente L., Picard F. Calorie restriction-the SIR2 connection. Cell 2005, 120:473-482.
9. Haigis M.C., Guarente L.P. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006, 20:2913-2921.
10. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., Grueter C.A., Harris C., Biddinger S., Ilkayeva O.R., Stevens R.D., Li Y., Saha A.K., Ruderman N.B., Bain J.R., Newgard C.B., Farese R.V., Alt F.W., Kahn C.R., Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
11. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
12. Jeon Y.H., Heo Y.S., Kim C.M., Hyun Y.L., Lee T.G., Ro S., Cho J.M. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell. Mol. Life Sci. 2005, 62:1198-1220.
13. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
14. Lavu S., Boss O., Elliott P.J., Lambert P.D. Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 2008, 7:841-853.
15. Mahlknecht U., Ho A.D., Voelter-Mahlknecht S. Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int. J. Oncol. 2006, 28:447-456.
16. Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem. J. 2007, 404:1-13.
17. Middelhaufe S., Garzia L., Ohndorf U.M., Kachholz B., Zollo M., Steegborn C. Domain mapping on the human metastasis regulator protein h-Prune reveals a C-terminal dimerization domain. Biochem. J. 2007, 407:199-205.
18. Milne J.C., Lambert P.D., Schenk S., Carney D.P., Smith J.J., Gagne D.J., Jin L., Boss O., Perni R.B., Vu C.B., Bemis J.E., Xie R., Disch J.S., Ng P.Y., Nunes J.J., Lynch A.V., Yang H., Galonek H., Israelian K., Choy W., Iffland A., Lavu S., Medvedik O., Sinclair D.A., Olefsky J.M., Jirousek M.R., Elliott P.J., Westphal C.H. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007, 450:712-716.
19. Nakagawa T., Lomb D.J., Haigis M.C., Guarente L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
20. Nemoto S., Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002, 295:2450-2452.
21. Norvell A., McMahon S.B. Cell biology. Rise of the rival. Science 2010, 327:964-965.
22. Pandolfi S., Bonafe M., Di Tella L., Tiberi L., Salvioli S., Monti D., Sorbi S., Franceschi C. p66(shc) is highly expressed in fibroblasts from centenarians. Mech. Ageing Dev. 2005, 126:839-844.
23. Pierre S., Eschenhagen T., Geisslinger G., Scholich K. Capturing adenylyl cyclases as potential drug targets. Nat. Rev. Drug Discov. 2009, 8:321-335.
24. Pinton P., Rimessi A., Marchi S., Orsini F., Migliaccio E., Giorgio M., Contursi C., Minucci S., Mantovani F., Wieckowski M.R., Del Sal G., Pelicci P.G., Rizzuto R. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007, 315:659-663.
25. Sauve A.A., Moir R.D., Schramm V.L., Willis I.M. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol. Cell 2005, 17:595-601.
26. Schlicker C., Gertz M., Papatheodorou P., Kachholz B., Becker C.F., Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 2008, 382:790-801.
27. Steegborn C., Litvin T.N., Levin L.R., Buck J., Wu H. Bicarbonate activation of adenylyl cyclase via promotion of catalytic active site closure and metal recruitment. Nat. Struct. Mol. Biol. 2005, 12:32-37.
28. Veeramani S., Yuan T.C., Lin F.F., Lin M.F. Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. Oncogene 2008, 27:5057-5068.
29. Wallace D.C., Fan W. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev. 2009, 23:1714-1736.
30. Xu W.S., Parmigiani R.B., Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007, 26:5541-5552.